The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5,5'-(8-(4-methyl-2-oxo-2H-chromen-7-yloxy)imidazo[1,2-a]pyrazine-3,6-diyl)bis(thiophene-5,2-diyl)diboronic acid ID: ALA4546072
PubChem CID: 155553309
Max Phase: Preclinical
Molecular Formula: C24H17B2N3O7S2
Molecular Weight: 545.17
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(=O)oc2cc(Oc3nc(-c4ccc(B(O)O)s4)cn4c(-c5ccc(B(O)O)s5)cnc34)ccc12
Standard InChI: InChI=1S/C24H17B2N3O7S2/c1-12-8-22(30)36-17-9-13(2-3-14(12)17)35-24-23-27-10-16(19-5-7-21(38-19)26(33)34)29(23)11-15(28-24)18-4-6-20(37-18)25(31)32/h2-11,31-34H,1H3
Standard InChI Key: HDICZOLKKPMHGJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
25.4730 -15.3601 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.1826 -14.9507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1798 -14.1280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4712 -13.7227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7649 -14.9511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7672 -14.1334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0613 -13.7243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3526 -14.1319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3543 -14.9528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0608 -15.3581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8910 -15.3581 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4677 -12.9055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6475 -15.3630 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9389 -14.9561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5267 -14.1445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5313 -14.9659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2397 -15.3690 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.2345 -13.7342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9410 -14.1389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5443 -13.5920 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2106 -12.8492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4011 -12.9372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8288 -15.3806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0803 -15.0526 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.5371 -15.6631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9499 -16.3685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7481 -16.1937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8479 -12.3325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0151 -11.5326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3060 -11.1264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7005 -11.6754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0356 -12.4207 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.8821 -11.6718 0.0000 B 0 0 0 0 0 0 0 0 0 0 0 0
18.4766 -10.9623 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4704 -12.3777 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7182 -15.6587 0.0000 B 0 0 0 0 0 0 0 0 0 0 0 0
17.3134 -14.9488 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3058 -16.3642 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 1 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 5 2 0
2 11 2 0
4 12 1 0
9 13 1 0
13 14 1 0
14 19 1 0
18 15 1 0
15 16 2 0
16 17 1 0
17 14 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 18 1 0
23 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 23 2 0
16 23 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 28 1 0
22 28 1 0
31 33 1 0
33 34 1 0
33 35 1 0
25 36 1 0
36 37 1 0
36 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 545.17Molecular Weight (Monoisotopic): 545.0694AlogP: ┄#Rotatable Bonds: ┄Polar Surface Area: ┄Molecular Species: ┄HBA: ┄HBD: ┄#RO5 Violations: ┄HBA (Lipinski): ┄HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: ┄CX LogD: ┄Aromatic Rings: ┄Heavy Atoms: ┄QED Weighted: ┄Np Likeness Score: ┄
References 1. Singh H, Singh JV, Bhagat K, Gulati HK, Sanduja M, Kumar N, Kinarivala N, Sharma S.. (2019) Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids., 27 (16): [PMID:31255497 ] [10.1016/j.bmc.2019.06.033 ]